August 17, 2017 The MSOAC approach to developing performance outcomes to measure and monitor multiple sclerosis disability
Development of a Harmonized Patient-Reported Outcome Questionnaire to Assess Myelofibrosis Symptoms in Clinical Trials
miR-122 An Exploratory Biomarker of Liver Injury: An Industry Perspective on the State of the Science and Experiences Pre-Clinically and Clinically The Critical Path Institute’s Predictive Safety Testing Consortium (PSTC) hosted a webinar focused on providing an industry pers
April 21, 2017 Development of the Diary for Irritable Bowel Syndrome Symptoms (DIBSS) to Assess Treatment Benefit in Clinical Trials: Foundational Qualitative Research
October 3, 2017 Mobile Devices in Clinical Trials for Neurological Diseases: CDISC Standards Development March 10, 2017 Pointe Hilton Tapatio Cliffs Resort | Phoenix, AZ Overview and Objectives The Coalition Against Major Diseas
February 1, 2017 A Drug Development Tool for Trial Enrichment in Patients With Autosomal Dominant Polycystic Kidney Disease
April 25, 2017 Second Annual Workshop on Clinical Outcome Assessments in Cancer Clinical Trials Event: Second Annual Workshop on Clinical Outcome Assessments in Cancer Clinical Trials Date: April 25, 2017 Location: Hyatt Rege
January 1, 2017 Evaluating the Non-Small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ): Results from the quantitative pilot study
April 11, 2016 Electronic Capture of Clinical Outcome Assessment Data: Why Is It Not Used More in Clinical Studies
